Best Sickle Cell Anemia Podcasts (2025)

1
CHIP & CCUS: advances in understanding and should we treat these precursor conditions? 16:48

Play Pause

3d ago16:48

16:48

In this episode of the VJHemOnc podcast, we explore clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - conditions increasingly recognized as early indicators of myelodysplastic syndromes and acute myeloid leukemia. Joining the discussion are leading experts George Vassiliou, MBBS, PhD, The U…

1
Diagnosing amyloidosis: identifying early signs, appropriate diagnostic tests, and challenges that remain 21:27

9d ago21:27

21:27

In this episode of the VJHemOnc podcast, we are joined by Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, a leading expert in the field, to discuss the complexities surrounding the diagnosis of amyloidosis, including both the light chain and ATTR subtypes. The conversation covers early clinical signs that clinicians often overlook, key differenc…

1
IPIG 2025 Highlights: challenging situations in PNH, updates from the COMMODORE trials, and more 20:16

18d ago20:16

20:16

VJHemOnc was the official media partner for the recent 2nd International PNH Interest Group (IPIG) Conference held in Paris, France. In today’s podcast episode, you will hear some highlights from the event from leading experts in the field of paroxysmal nocturnal hemoglobinuria (PNH). First, Jens Panse, MD, Aachen University Hospital, Aachen, Germa…

1
Recent advances in Hodgkin lymphoma treatment: novel regimens, ongoing trials & treating R/R disease 11:43

25d ago11:43

11:43

In this episode of the VJHemOnc podcast, join us for an insightful conversation with Dr Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Dr Collins discusses the significant shifts in treatment approaches for patients with advanced-stage classical Hodgkin lymphoma over the past decade. He…

1
Gene therapy in sickle cell disease: patient selection, potential complications, & more 21:19

1M ago21:19

21:19

In this episode of the VJHemOnc podcast you will hear from Akshay Sharma, MBBS, MSc, St. Jude Children’s Research Hospital, Memphis, TN, who takes a deep dive into gene therapy for the treatment of sickle cell disease (SCD). Dr Sharma begins by discussing the status of gene therapy in SCD, outlining considerations for clinicians when selecting pati…

1
Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community 23:38

1M ago23:38

23:38

Today's VJHemOnc podcast features discussions from the 7th International Workshop on CAR-T and bispecifics (iwCAR-T) 2025, which was held recently in Miami, FL. First you will hear from Elizabeth Budde, MD, PhD, City of Hope, Duarte, CA, Mohammad Rashidian, PhD, Dana-Farber Cancer Institute, Boston, MA, Michael Jain, MD, PhD, H. Lee Moffitt Cancer …

1
Sickle Cell Advocacy: Stories, Struggles, and Self-Care 37:45

1M ago37:45

37:45

On this episode of Cheat Codes, guest host Janie Davis, Director of Patient Advocacy at Agios Pharmaceuticals, is joined by sickle cell advocates Teonna Woolford, Cassandra Trimnell, and Rae Blaylark discuss the challenges and rewards of sickle cell advocacy. They delve into personal journeys, the nuances of advocacy, and the importance of self-car…

1
Updates to the ESMO CLL clinical practice guidelines and implications for relapsed therapy 19:49

2M ago19:49

19:49

This episode features leading experts Paolo Ghia, MD, Vita-Salute San Raffaele University, Milan, Italy, and Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, Netherlands, who provide key insights into the management of relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), guided by the latest ESMO clinical practice recommendations.…

1
ID or Jail: The Arrest of John Choe 25:25

2M ago25:25

25:25

On this episode, we dive into the unsettling story of John Choe—a traveling minister who found himself in handcuffs on a rainy Sunday afternoon, all because he chose not to show his ID.

1
Highlights from iwMyeloma 2025: trial updates and practical considerations 35:15

2M ago35:15

35:15

VJHemOnc was delighted to be media partners for the 18th International Workshop on Multiple Myeloma (iwMyeloma), held in Miami, FL. This podcast episode features highlights from the meeting. First, you will hear from Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ, Ola Landgren, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL…

1
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment 34:35

2M ago34:35

34:35

In this VJHemOnc podcast, experts Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, Lydia Scarfò, MD, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan, Italy, and Anna Schuh, MD, PhD, University of Oxford, Oxford, UK, provide insights into the latest updates to the ESMO clinical practice gui…

1
Highlights from EBMT 2025: preventing and managing GvHD, harnessing AI in transplant, & more 22:53

2M ago22:53

22:53

In this week’s VJHemOnc podcast, we’ll be sharing highlights from the 51st Annual Meeting of the EBMT, with a focus on the prevention and management of graft-versus-host disease (GvHD) and infections associated with stem cell transplantation (SCT). You will also hear about the potential of artificial intelligence (AI) in hematology and transplantat…

1
Legends of Sickle Cell Disease: Dr. Isaac Odame’s Journey 45:44

2M ago45:44

45:44

On this episode, Dr. Z and Dr. C. Callahan interview Dr. Isaac Odame, a leading figure in the field of sickle cell disease. Dr. Odame shares his life story, beginning in Ghana, his medical training in the UK, and his global contributions to sickle cell research, including involvement with the Global Sickle Cell Disease Network. The discussion cover…

1
Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more! 46:21

2M ago46:21

46:21

This podcast episode features experts Paolo Strati, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Gloria Iacoboni, MD, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, and Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, who discuss the sequencing of therapies in relapsed/refractory (R/R) non-Hod…

1
Novel CAR strategies being explored in lymphoma: allogeneic products, trispecific CARs & new manufacturing platforms 18:06

3M ago18:06

18:06

CAR T-cell therapy has revolutionized the lymphoma treatment landscape in recent years. In this episode, we delve into cutting-edge CAR strategies being investigated for lymphoma, including allogeneic products, trispecific CARs, and more. Key highlights include insights into CTX112, a next-generation allogeneic CRISPR-Cas9 engineered CD19 CAR T-cel…

1
Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more! 23:26

3M ago23:26

23:26

Newly diagnosed acute myeloid leukemia (AML) is traditionally treated with intensive chemotherapy for eligible patients, but ongoing research is exploring the addition of targeted agents. This podcast focuses on approaches being explored to optimize induction therapy in AML, featuring experts Tapan Kadia, MD, The University of Texas MD Anderson Can…

1
Championing Sickle Cell Care: A Talk with Dr. Wally Smith 44:55

3M ago44:55

44:55

Drs. Z and C welcome Dr. Wally Smith, a leading figure in sickle cell research from Virginia Commonwealth University, to discuss crucial issues affecting adults with sickle cell disease. They explore the neglect of adult patients, the need for dedicated centers, and the value of community health workers. Dr. Smith emphasizes the importance of holis…

1
Treating R/R mantle cell lymphoma: the role of BTK inhibitors, combination approaches being explored & overcoming resistance 16:52

3M ago16:52

16:52

BTK inhibitors have transformed the treatment landscape in both frontline and relapsed/refractory (R/R) mantle cell lymphoma (MCL), offering a targeted therapy option for patients. In this podcast, you will hear from Krish Patel, MD, Sarah Cannon Cancer Institute, Nashville, TN, Yucai Wang, MD, PhD, Mayo Clinic, Rochester, MN, Julie Vose, MD, Unive…

1
Addressing unmet needs in myeloma: early detection, frail/elderly patients, triple-class exposed disease, & more! 27:48

3M ago27:48

27:48

In recognition of Myeloma Awareness Month 2025, this podcast explores key unmet needs and unanswered questions in myeloma research and patient care, offering insights and strategies for healthcare professionals to address them. The discussion centers on four topics: the treatment of smoldering myeloma, managing frail and elderly patients, challenge…

1
CAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes 18:39

4M ago18:39

18:39

CAR T-cell therapy has become an established treatment for several hematological malignancies, including acute lymphoblastic leukemia (ALL), and has significantly changed the therapeutic landscape for patients. In this podcast episode, renowned experts will share insight into the use of CAR-T in ALL, including updates of pivotal trials, novel appro…

1
Timmerman Hike: A Journey of Hope and Advocacy for Sickle Cell 45:56

4M ago45:56

45:56

On this inspiring episode of Cheat Codes, Dr. Z and Dr. C talk with an extraordinary group of individuals who embarked on a monumental climb up Mount Kilimanjaro to raise awareness and funds for sickle cell disease. Led by Dr. Alan Anderson and featuring sickle cell warrior Jimi Olaghere the group of Patrick Hines, MD, PhD, Eva Gallagher, PhD, and …

1
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more! 13:15

4M ago13:15

13:15

Today's podcast features a discussion with experts Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, and Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London Hospitals NHS Foundation Trust, London, UK, from the 66th ASH Annual Meeting and Exposition. They share their key highlights in amyloidosis fr…

1
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia 18:27

4M ago18:27

18:27

This episode of the VJHemOnc podcast covers updates in non-malignant hematological diseases from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear the latest updates in sickle cell disease (SCD), thalassemia, and hemophilia from leading experts. First, Sophia Delicou, MD, H…

1
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025 18:29

5M ago18:29

18:29

This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held in San Diego, CA. In this episode, experts Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Cen…

1
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML 28:59

5M ago28:59

28:59

In this podcast, we bring you exclusive updates on acute myeloid leukemia (AML) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear insights into novel approaches to frontline chemotherapy and BCL2 inhibition from experts Ioannis Mantzaris, MD, Montefiore Medical Center/…

1
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more! 22:21

5M ago22:21

22:21

This podcast episode covers key highlights in myeloproliferative neoplasms (MPNs) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear key trial updates in myelofibrosis (MF) from Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL, Lucia Masarova, MD, The Univ…

1
Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting 31:20

5M ago31:20

31:20

Today's podcast showcases key updates in non-Hodgkin lymphoma (NHL) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear from Gilles Salles, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, Catherine Diefenbach, MD, NYU Langone, New York, NY, and Jia …

1
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS 19:02

5M ago19:02

19:02

This podcast is the second episode in our series spotlighting key highlights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. This episode focuses on updates in myelodysplastic syndromes (MDS). You will hear insights into managing anemia in lower-risk MDS (LR-MDS) from Sophie Park,…

1
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more! 16:31

6M ago16:31

16:31

VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we gained expert insights into cutting-edge research in hematological malignancies. This podcast series will cover highlights in a variety of disease areas. Today's episode focuses on chronic lymphocytic leukemia (CLL). You…

1
Battling Sickle Cell Anemia and Discrimination in Healthcare 31:01

6M ago31:01

31:01

A group of Black women in Athens, Georgia suffering from sickle cell anemia, report that a doctor at the local Hospitals have repeatedly denied them necessary treatment, downplayed the severity of their condition, and insinuated they were seeking drugs rather than medical care. Similar experiences have occurred at both Piedmont and St. Mary’s Hospi…

1
Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents 28:52

6M ago28:52

28:52

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone marrow, and lymph nodes, often associated with a poor prognosis. In this podcast episode, Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an in-depth explo…

1
Improving care for patients with SCD: pain management, ongoing projects & unmet needs 16:45

7M ago16:45

16:45

This week's podcast focuses on strategies to improve care for patients with sickle cell disease (SCD), featuring expert insights from the 19th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT 2024), which was held in London, UK. You will hear from Natasha Archer, MD, MPH, Harvard Medical School, Boston, MA, Subarna Chakravorty, MB…

1
Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care 34:43

7M ago34:43

34:43

In this podcast, experts Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute, Boston, MA, Nicole LeBoeuf, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, and Shai Shimony, MD, Dana-Farber Cancer Institute, Boston, MA, share insights into the clinical presentation, diagnosis, and treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN…

1
Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more! 21:36

7M ago21:36

21:36

Today's podcast episode focuses on the management of complications associated with Waldenström's macroglobulinemia (WM), featuring expert insights from the 12th International Workshop on Waldenström's Macroglobulinemia (IWWM-12) held in Prague, Czech Republic. You will hear from Shirley D’Sa, MD, FRCP, FRCPath, University College London, London, UK…

1
How my mother’s passing led to my first Sickle Cell Crisis in over five years. 14:58

7M ago14:58

14:58

In this deeply personal episode , I share the story of how my mother's passing triggered my first sickle cell crisis in over five years. Losing her was an emotionally overwhelming experience, and I never expected that the stress and grief would manifest physically in such a powerful way. I walk you through the emotional and physical toll that the l…

1
CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024 24:59

8M ago24:59

24:59

This week's podcast features discussions on the use of immunotherapy in the treatment of high-risk multiple myeloma (HRMM) from the 1st International Workshop on High-Risk Multiple Myeloma (iwHRMM), which took place Charleston, SC. You will hear from experts Ajai Chari, MD, University of California San Francisco, San Francisco, CA, and Krina Patel,…

1
Changing the Narrative: Stories of Black Entrepreneurship. P2. Barnard Sims & Maxim 32:52

7M ago32:52

32:52

Interview with Barnard Sims, The Barber and award-winning author. Joining him is Maxim, a seasoned poet, entrepreneur, and owner of Food Truck Builders A-Z and Da Munchies. Together, we're diving deep into the world of Black businesses and what it takes to thrive.

1
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS 22:39

8M ago22:39

22:39

This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix, AZ. You will hear from Anand Patel, MD, University of Chicago Medical Center, Chicago, IL, Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY, Guillermo Montalban-Bravo, MD, The Universit…

1
Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events 9:29

8M ago9:29

9:29

Today's podcast focuses on the role of BTK inhibitors (BTKis) in the treatment of mantle cell lymphoma (MCL). You will hear from experts Krish Patel, MD, Providence Swedish Cancer Institute, Seattle, WA, Marek Trněný, MD, PhD, Charles University Hospital, Prague, Czech Republic, Michael Wang, MD, The University of Texas MD Anderson Cancer Center, H…

1
An update on menin inhibition in AML from iwAL 2024: current data, mechanisms of resistance, & more! 16:34

8M ago16:34

16:34

Menin inhibitors are emerging as a promising therapeutic approach in acute myeloid leukemia (AML), particularly in patients with specific genetic mutations such as KMT2A-rearranged and NPM1-mutated AML. These inhibitors disrupt the leukemogenic signaling pathways that drive leukemia cell proliferation by blocking the actions of menin. They can help…

1
Tabatha McGee Means Business 39:23

8M ago39:23

39:23

On this episode of Cheat Codes, Dr. Z and Dr. C are joined by Tabatha McGee, Executive Director of the Sickle Cell Foundation of Georgia. Tabatha shares her remarkable journey from systems engineer to leading the foundation, driven by a personal mission to enhance the lives of sickle cell warriors. The discussion delves into innovative programs lik…

1
CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024 20:30

8M ago20:30

20:30

Today's podcast features discussions from the 21st International Workshop on Non-Hodgkin Lymphoma (iwNHL) which took place in Nice, France. You will hear updates on the use of CAR T-cell therapy in non-Hodgkin lymphoma (NHL) from experts Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children’s National Health System, Washington, DC, Stephen Schuster,…

1
Changing the Narrative: Stories of Black Entrepreneurship. P1: Bernard Anderson 25:29

8M ago25:29

25:29

Interview w/Bernard Anderson owner of Jet Cuts Barbershop located in Athens, Georgia.

1
Prolonging remission in AML: current approaches & future outlooks 31:27

9M ago31:27

31:27

Today's podcast features a discussion with leading experts Harry Erba, MD, PhD, Duke University, Durham, NC, Farhad Ravandi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Thomas Cluzeau, MD, PhD, Central University Hospital of Nice, Nice, France, on strategies to prolong remission in acute myeloid leukemia (AML). They focu…

1
A focus on the use of artificial intelligence to personalize blood cancer care 28:55

9M ago28:55

28:55

Welcome to the final episode of VJHemOnc's Blood Cancer Awareness Month special series! This episode focuses on the role of artificial intelligence (AI) in personalizing blood cancer care. Carsten Niemann, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, discusses the value of AI in hematological oncology and how it is currently used i…

1
From Omaha to Global Health: Dr. Xu's Path in Hematology 48:16

9M ago48:16

48:16

On this episode, Dr. Z and Dr. C welcome Dr. Julia Xu, a rising star in the field of sickle cell disease. Dr. Xu shares her inspiring journey from Omaha, Nebraska, to her current role at the University of Pittsburgh. The discussion covers her extensive background in global health, her research on anemia in sickle cell disease, and the impactful men…

1
A focus on pediatric leukemias: trials, treatments, & challenges 17:44

9M ago17:44

17:44

Welcome to the third episode of VJHemOnc’s Blood Cancer Awareness Month special series! The focus of this episode is pediatric acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). You will hear from Michele Redell, MD, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX, who shares insights into the Pediatric Acu…

1
A focus on the psychosocial impacts of living with blood cancer 36:22

9M ago36:22

36:22

Welcome to the second episode of VJHemOnc’s Blood Cancer Awareness Month special series! Today's episode focuses on the psychosocial impacts of living with blood cancer. First, you will hear from Lorna Warwick, BA, Lymphoma Coalition, Toronto, Canada, who shares the work of the Lymphoma Coalition Global Patient Survey. Next, you will hear insights …